← Open Payments lookup

ELIZABETH FINSNESS: Open Payments

NPI 1649877101 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,221 in 222 payments from 21 companies in 2025. Trend: 2023 $7,905 · 2024 $4,277 · 2025 $5,221

Food & beverage: $4,971Education: $250
CompanyPaymentsAmount
Janssen Biotech, Inc.34$676
Regeneron Healthcare Solutions, Inc.11$621
UCB, Inc.19$576
GENZYME CORPORATION15$502
ABBVIE INC.31$465
PFIZER INC.18$374
Galderma Laboratories, L.P.14$352
SUN PHARMACEUTICAL INDUSTRIES INC.13$313
Arcutis Biotherapeutics, Inc.17$236
Botanix SB Inc11$225

Products named: DUPIXENT, TREMFYA, Bimzelx, NEMLUVIO, SKYRIZI, CIBINQO, Zoryve, SOFDRA.

Industry payments across TX — which companies pay providers there.